ArticleFrontiers in pharmacology2025
The biological function and prognostic significance of ferroptosis-related genes in clear cell renal cell carcinoma.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ferroptosis in renal cell carcinoma: integrative multi-omics insights and therapeutic perspectives.International journal of surgery (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ferroptosis-related genes are essential in cancer development. However, the specific roles of ferroptosis-related genes in clear cell renal cell carcinoma (ccRCC) remain largely unexplored. This study aims to elucidate the biological functions and potential therapeutic implications of ferroptosis-related genes in ccRCC. Methods: A model integrating the Cancer Genome Atlas (TCGA) database and the GEO dataset was established based on ferroptosis-related genes and clinical data. To determine the proliferative function of ferroptosis-related genes in ccRCC cells, CCK-8 kit assays and colony formation experiments were conducted. Additionally, wound-healing experiments were performed to evaluate the migratory capabilities of these cells. Results: We identified eight ferroptosis-related genes that are significantly associated with the prognosis of ccRCC patients. The expression levels of these genes exhibited marked differences between tumor tissues and normal tissues, and they were shown to influence both the proliferation and metastasis of ccRCC cells. Subsequently, a model combining ferroptosis-related genes model constructed with gene data and clinical characteristics was constructed, and classified the patients into high- and low-risk groups. The area under the curve (AUC) for this model in diagnosing ccRCC was 0.937. In terms of survival prediction, the AUC values were 0.875, 0.818, and 0.790 at 1, 3, and 5 years, respectively. Notably, high-risk patients exhibited significantly poorer survival outcomes compared to those in the low-risk group. Furthermore, high-risk individuals demonstrated elevated expression of immune checkpoint genes and enhanced antitumor immunity, suggesting that these patients may benefit from immunotherapy. Conclusion: Ferroptosis-related genes play a critical role in the biological functions of ccRCC cells. Our prognostic model has the potential to be applied in predicting patient outcomes and assessing antitumor immunity in ccRCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.